http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#Head http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#assertion http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#provenance http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#pubinfo http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#assertion http://purl.obolibrary.org/obo/DOID_14654 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_14654 http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00567 http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association http://www.w3.org/2000/01/rdf-schema#label cephalexin is a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria respiratory tract infection 1 1 otitis media 1 2 skin and skin structure infections 1 3 bone infections 1 4 genitourinary tract infections 1 5 to reduce the development of drug resistant bacteria and maintain the effectiveness of cephalexin capsules cephalexin for oral suspension and cephalexin tablets and other antibacterial drugs cephalexin capsules cephalexin for oral suspension and cephalexin tablets should be used only to treat infections that are proven or strongly suspected to be caused by bacteria 1 6 cephalexin is indicated for the treatment of respiratory tract infections caused by susceptible isolates of streptococcus pneumoniae streptococcus pyogenes cephalexin is indicated for the treatment of otitis media caused by susceptible isolates of streptococcus pneumoniae haemophilus influenzae staphylococcus aureus streptococcus pyogenes moraxella catarrhalis cephalexin is indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following gram positive bacteria staphylococcus aureus streptococcus pyogenes cephalexin is indicated for the treatment of bone infections caused by susceptible isolates of staphylococcus aureus proteus mirabilis cephalexin is indicated for the treatment of genitourinary tract infections including acute prostatitis caused by susceptible isolates of escherichia coli proteus mirabilis klebsiella pneumoniae to reduce the development of drug resistant bacteria and maintain the effectiveness of cephalexin capsules cephalexin for oral suspension and cephalexin tablets and other antibacterial drugs cephalexin capsules cephalexin for oral suspension and cephalexin tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information is available this information should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00567 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#provenance http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#pubinfo http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#sig http://purl.org/nanopub/x/hasSignature BcTRu5VM9adT5/mHKquzCS6sBBa0uOtDI0Wv5nleAPRXKQtPDrLsg5A4BUWKUhHMjAqhnweHAAp3JC+/78+LPZe5daB/3Qtp6ZMqgawQQdKXjiMluMAyqukYzIsSQHzVYAbeUTI7bSJgyIJs741zBy46xWl3EC1kzV/6UF6mt4A= http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA http://purl.org/dc/terms/created 2021-06-13T15:56:39.798+02:00 http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs